Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

474 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Prognostic factors for febrile neutropenia].
Ray-Coquard I, Borg C, Bachelot T, Fayette J, Zufferey L, Guastalla JP, Ghesquière H, Blay JY, Sebban C, Marec-Bérard P, Biron P. Ray-Coquard I, et al. Among authors: borg c. Bull Cancer. 2006 May;93(5):501-6. Bull Cancer. 2006. PMID: 16777629 Free article. Review. French.
Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients.
Ménard C, Blay JY, Borg C, Michiels S, Ghiringhelli F, Robert C, Nonn C, Chaput N, Taïeb J, Delahaye NF, Flament C, Emile JF, Le Cesne A, Zitvogel L. Ménard C, et al. Among authors: borg c. Cancer Res. 2009 Apr 15;69(8):3563-9. doi: 10.1158/0008-5472.CAN-08-3807. Epub 2009 Apr 7. Cancer Res. 2009. PMID: 19351841 Clinical Trial.
CD4 lymphopenia to identify end-of-life metastatic cancer patients.
Péron J, Cropet C, Tredan O, Bachelot T, Ray-Coquard I, Clapisson G, Chabaud S, Philip I, Borg C, Cassier P, Labidi Galy I, Sebban C, Perol D, Biron P, Caux C, Menetrier-Caux C, Blay JY. Péron J, et al. Among authors: borg c. Eur J Cancer. 2013 Mar;49(5):1080-9. doi: 10.1016/j.ejca.2012.11.003. Epub 2012 Dec 13. Eur J Cancer. 2013. PMID: 23246297
Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects.
Borg C, Terme M, Taïeb J, Ménard C, Flament C, Robert C, Maruyama K, Wakasugi H, Angevin E, Thielemans K, Le Cesne A, Chung-Scott V, Lazar V, Tchou I, Crépineau F, Lemoine F, Bernard J, Fletcher JA, Turhan A, Blay JY, Spatz A, Emile JF, Heinrich MC, Mécheri S, Tursz T, Zitvogel L. Borg C, et al. J Clin Invest. 2004 Aug;114(3):379-88. doi: 10.1172/JCI21102. J Clin Invest. 2004. PMID: 15286804 Free PMC article.
474 results